MarketScreener Editorial Features Genscript Biotech Corporation

Stocks

Market Closed - Hong Kong S.E. Other stock markets 09:08:41 13/07/2026 BST			5-day change	1st Jan Change
14.32 ^HKD	+3.47%		+2.36%	+15.30%

06-15	Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma	MT
06-14	Genscript Biotech Corporation Reports 100% Response Rate in Early Trial of LB2501 Dual-Targeting CAR-T Therapy for Relapsed B-Cell Lymphoma	CI

No results match your criteria